Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
KC, Gayathiri; Murugesan, Mohandoss; Nayanar, Sangeetha K; Malodan, Riyas; Padmanaban, Maya.
Hematol., Transfus. Cell Ther. (Impr.)
; 43(2): 179-184, Apr.-June 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1286689
Documentos relacionados
Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system.
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada.
Evaluation of the Lyophilized Platelets Function by Thromboelastography in an In Vitro Platelet Transfusion Model.
Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matching.
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Implementation strategy for complete pathogen reduction technology treated apheresis platelet inventory.
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).
Whole blood derived and apheresis platelets: Opinions and preferences-the results of a national survey of blood collectors.
Platelet decrease and efficacy of platelet-rich plasma return following peripheral blood stem cell apheresis.
Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.